Who we helpSadly, Breast Cancer claims the lives of around 12,000 women each year.
The number of women being diagnosed is rising, but the good news is that with your help, more women are surviving the disease than ever before. Learn More
Scientists have raised the possibility of using statins, cholesterol reducing drugs, to stop some breast cancers returning. The most common form of breast cancer in the UK is oestrogen receptor (ER) positive which uses oestrogen to grow. Hormone therapy drugs such as ‘tamoxifen’ and aromatase inhibitors cut off the supply of oestrogen, reducing the chances the ...more
Earlier this week saw an agreement signed between UK cancer clinical trial centers making new clinical trials easier and more efficient to set up. The Experimental Cancer Medical Centre (ECMC) collaboration agreement will improve the UK’s ability to carry out early phase trials, boosting research to bring new treatments to patients sooner. The UK currently faces ...more
According to research published in the journal Oncogene earlier this week, researchers from Nottingham and Oxford Universities have found a new technique to slow the growth of one of the most aggressive forms of breast cancer. The drug, called JQ1, has shown promising results both in vitro and on human cancer cells in mice, and ...more
Dr Niamh Buckley and her team at Queen’s University Belfast, have discovered a way to predict the likelihood that women who are diagnosed with non-invasive breast cancer will go on to develop an invasive form of the disease. This information could enable doctors to tailor the patient’s treatment to their specific needs. In the UK there ...more
Personalised treatment for breast cancer could become commonplace as scientists reveal they have compiled the most detailed picture of which genetic mutations are involved in the disease. The findings were published in the journals ‘Nature’ and ‘Nature Communications’ and explain which genes cause healthy breast tissue to turn cancerous. Researchers from the Sanger Institute in Cambridge ...more
Following on from last week’s article Scientists hail ‘Milestone’ genetic find for breast cancer which looked at which mutated genes are more likely to cause cancer, scientists have been able to use this data to analyse that breast cancer can be classified into 10 different diseases. By researching these 10 subtypes of breast cancer scientists at ...more
Reported in the press today was the fact that more than 800 people a day are diagnosed with cancer in England. Figures show that the number is rising, with 296,863 new cases in 2014. Breast, lung, prostate and bowel cancers account for more than half of cases, says the Office for National Statistics.more
We are delighted to announce that our corporate partner Hastings Direct raised over £104,400 for the Pink Ribbon Foundation in 2015. The general insurance provider raised the charitable monies via Hastings Direct brand, insurePink where £10 from every car and home, and £1 from every travel insurance policy sold online is donated to the Foundation. ...more
Researchers at The Institute of Cancer Research have discovered that more aggressive forms of breast cancer secrete a protein called Wnt7a which recruits and mutates surrounding cells to promote the spread of the disease. The team examined nearly 900 breast cancer samples and found that women who had high levels of Wnt7a were at higher ...more
A leading scientist from Birmingham has been awarded a grant of more than £200,000 by research charity Breast Cancer Now to study how a particular molecule called PRMT5 might be helping breast cancer stem cells survive – making tumours more likely to grow back after treatment. Breast stem cells are a rare group of cells ...more
Jonathan Prince, Trustee. The Pink Ribbon Foundation.
Crofton House, 5 Morley Close, Orpington, Kent BR6 8JR
(t) 01689 858877 (e) firstname.lastname@example.org.
Charity Number 1080839